Advanced healthcare materials
A Pathophysiology-Informed, Negentropy-Oriented Strategy for Nanomedicine in MASLD.
Rui Mao, Meng Yu, Xiu-Ping Guo, Xiao-Lian Tian, Meng-Yu Zhao, Quan-Yong Yu, Gang Ren, Ming-Yu Pan, Ru Bai, Li-Ping Liu, Gui-Ling Li, Jian-Dong Jiang, Lu-Lu Wang
Published: 202510.1002/adhm.202504298
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multifactorial chronic liver disorder driven by an ensemble of interrelated pathological processes, including insulin resistance, lipid accumulation, oxidative stress, immune dysre…
Preview only. Read the full abstract at the source